| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |